Baxter/Cangene Add Intravascular Hemolysis Warning To WinRho SDF Labeling
This article was originally published in The Pink Sheet Daily
Executive Summary
Updated WinRho SDF labeling also warns against falsely elevated blood glucose levels associated with use of the bleeding disorder therapy.